APOE and Alzheimer disease: Despite the well-documented connection between APOE ε4 and neuropathological processes implicated in AD [18], it is important to highlight that also non-ε4 carriers develop AD which illustrates that other factors (i.e., environment, race/ethnicity, sex) may independently or synergistically promote or modify the risk of AD.